Document:

Exhibit 10.15

 

Agreement

 

This Agreement (this "Agreement"), effective
as of September 20, 2018 (the "Effective Date"), is by and between MYnd Analytics, Inc., ("Company")
and RSJ INVESTMENTS SICAV A.S. ACTING IN RESPECT OF ITS SUB-FUND (PODFOND) RSJ GRADUS PODFOND, RSJ INVESTMENT SICAV A.S. ("RSJ").
Company and RSJ may be referred to herein collectively as the "Parties" or individually as a "Party."

 

WHEREAS, Company desires to license or distribute the Company’s
technology and/or intellectual property in Europe; and

 

WHEREAS, RSJ desires a right of first refusal to license or
distribute the Company’s technology and/or intellectual property in Europe for the Term (as defined below) of this Agreement.

 

NOW, THEREFORE, in consideration of the mutual covenants, terms,
and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties agree as follows:

 

 1.             RIGHT OF FIRST REFUSAL

 

1.1           Right
of First Refusal. For a period from the date hereof until September 30, 2019 (“Term”), the Company shall not enter
into any agreement with any third party that includes the grant by the Company to such third party of any license or distribution
rights with respect to any of the Company’s technology and/or intellectual property in Europe (“Rights”), unless
the Company first offers RSJ the right to license or distribute such technology in Europe in accordance with this Section 1.

 

1.2.          Process.
Prior to the Company entering into any agreement relating to the Rights during the Term, the Company shall first give written notice
thereof to RSJ (the “ROFR Notice”). The ROFR Notice shall identify the proposed technology to be covered by the agreement,
describe all material terms of the proposed agreement and offer RSJ the option to provide to the Company, within 30 calendar days
of RSJ’s receipt of the ROFR Notice (the “ROFR Period”), a final proposed agreement (which may be similar to
the terms in such Notice or on such other terms as RSJ shall elect) pursuant to which the Company will grant to RSJ, or a wholly-owned
subsidiary of RSJ designated by RSJ, license or distribution rights with respect to the Company’s technology and/or intellectual
property in Europe (the “RSJ Proposed Agreement”). During the time period while RSJ is considering these terms, the
Company shall discuss the proposed terms with RSJ as reasonably requested. The delivery by RSJ, or a wholly-owned subsidiary of
RSJ (the “RSJ Subsidiary”), to the Company of the RSJ Proposed Agreement shall constitute a binding offer by RSJ, or
the RSJ Subsidiary, to the Company to enter into the RSJ Proposed Agreement on the terms set forth therein, which may be accepted
by the Company at any time within 30 calendar days of the Company’s receipt of the RSJ Proposed Agreement (the “ROFR
Acceptance Period”).

 

1.3           End
of Period. If RSJ, or the RSJ Subsidiary, fails to deliver to the Company, before the expiration of the ROFR Period, the RSJ Proposed
Agreement, then the Company shall be free to enter into an agreement with any third party with respect to the Rights on such terms
as the Company shall elect in its sole discretion.

 

1.4           Acceptance.
If RSJ, or the RSJ Subsidiary, delivers to the Company, before the expiration of the ROFR Period, the RSJ Proposed Agreement, then
the Company shall in good faith compare the terms of the RSJ Proposed Agreement to the material terms of the third party agreement
as set out in the ROFR Notice, and, if the Company in good faith determines (taking into account all of the terms contained therein,
both financial and otherwise, but not taking into account any terms of the third party agreement that were not set out in the ROFR
Notice) that the value of the RSJ Proposed Agreement to the Company equals or exceeds the value of the third party agreement to
the Company, then the Company shall enter into the RSJ Proposed Agreement. If the Company in good faith determines (taking into
account all of the terms contained therein, both financial and otherwise, but not taking into account any terms of the third party
agreement that were not set out in the ROFR Notice) that the value of the RSJ Proposed Agreement to the Company is less than the
value of the third party agreement to the Company, then the Company may enter into the third party agreement without any further
obligation to RSJ under this Section 1.

 

    	 

     

    

 

1.5           Transfer
of License. If the Company and RSJ, or the Company and the RSJ Subsidiary, enter into the RSJ Proposed Agreement, RSJ or the RSJ
Subsidiary may assign the license or distribution rights with respect to the Company’s technology and/or intellectual property
in Europe to the RSJ Subsidiary or any other wholly-owned subsidiary of RSJ.

 

2.             CONFIDENTIAL
INFORMATION. From time to time during the Term, either Party may disclose or make available to the other
Party information about its business affairs, products, confidential intellectual property, trade secrets, third-party confidential
information, and other sensitive or proprietary information, whether orally or in written, electronic, or other form
or media, and whether or not marked, designated or otherwise identified as "confidential" (collectively, "Confidential
Information"). Confidential Information does not include information that, at the time of disclosure is: (a) in the public
domain; (b) known to the receiving Party at the time of disclosure; (c) rightfully obtained by the receiving Party on a non-confidential
basis from a third party; or (d) independently developed by the receiving Party. The receiving Party shall not disclose the disclosing
Party's Confidential Information to any person or entity, except to the receiving Party's employees and advisors who have a need
to know the Confidential Information for the receiving Party to exercise its rights or perform its obligations hereunder. Notwithstanding
the foregoing, each Party may disclose Confidential Information to the limited extent required (i) in order to comply with the
order of a court or other governmental body, or as otherwise necessary to comply with applicable law, provided that the Party making
the disclosure pursuant to the order shall first have given written notice to the other Party and made a reasonable effort to obtain
a protective order; or (ii) to establish a Party's rights under this Agreement, including to make required court filings. On the
expiration or termination of this Agreement, the receiving Party shall promptly return to the disclosing Party all copies, whether
in written, electronic, or other form or media, of the disclosing Party's Confidential Information, or destroy all such copies
and certify in writing to the disclosing Party that such Confidential Information has been destroyed. Each Party's obligations
of non-disclosure with regard to Confidential Information are effective as of the Effective Date and will expire five years from
the date first disclosed to the receiving Party; provided, however, with respect to any Confidential Information that constitutes
a trade secret (as determined under applicable law), such obligations of non-disclosure will survive the termination or expiration
of this Agreement for as long as such Confidential Information remains subject to trade secret protection under applicable law.

 

3.            MISCELLANEOUS.

 

3.1           Entire
Agreement. This Agreement, constitutes the sole and entire agreement of the Parties with respect to the subject matter of this
Agreement and supersedes all prior and contemporaneous understandings, agreements, and representations and warranties, both written
and oral, with respect to such subject matter.

 

3.2           Amendment and Modification; Waiver. No amendment to or modification of this Agreement is effective unless it is in writing and
signed by an authorized representative of each Party. No waiver by any Party of any of the provisions hereof will be effective
unless explicitly set forth in writing and signed by the Party so waiving. Except as otherwise set forth in this Agreement, no
failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or
be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude
any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.

 

    	2

     

    

 

3.3           Governing
Law; Submission to Jurisdiction. This Agreement is governed by and construed in accordance with the internal laws of the State
of Delaware without giving effect to any choice or conflict of law provision or rule that would require or permit the application
of the laws of any jurisdiction other than those of the State of Delaware. Any legal suit, action, or proceeding arising out of
or related to this Agreement may be instituted in the federal courts of the United States or the courts of the State of Delaware
of, and each Party irrevocably submits to the jurisdiction of such courts in any such suit, action, or proceeding.

 

3.4           Assignment.
Neither Party may assign or transfer any of its rights or delegate any of its obligations hereunder, in each case whether voluntarily,
involuntarily, by operation of law or otherwise, without the prior written consent of the other Party, which consent will not be
unreasonably withheld, conditioned, or delayed; provided, however, that either Party may assign its rights or delegate its obligations,
in whole or in part, without such consent and upon 15 business days prior written notice to the other Party, to (i) one or more
of its affiliates, or (ii) an entity that acquires all or substantially all of the business or assets of such Party to which this
Agreement pertains, whether by merger, reorganization, acquisition, sale, or otherwise. Any purported assignment, transfer, or
delegation in violation of this Section will be null and void. No assignment, transfer, or delegation will relieve the assigning
or delegating Party of any of its obligations hereunder. This Agreement is binding upon and inures to the benefit of the Parties
hereto and their respective permitted successors and assigns.

 

3.5           Equitable
Relief. Each Party acknowledges and agrees that a breach or threatened breach by such Party of any of its obligations under Section
2 would cause the other Party irreparable harm for which monetary damages would not be an adequate remedy and agrees that, in the
event of such breach or threatened breach, the other Party will be entitled to equitable relief, including a restraining order,
an injunction, specific performance, and any other relief that may be available from any court, without any requirement to post
a bond or other security, or to prove actual damages or that monetary damages are not an adequate remedy. Such remedies are not
exclusive and are in addition to all other remedies that may be available at law, in equity, or otherwise.

 

3.6           Publicity.
The Parties agree that either party may issue a press release regarding this Agreement or the relationship of the Parties upon
written authorization from the other Party. However, the Parties acknowledge that each Party is subject to public disclosure requirements
and that the existence of this Agreement or the Parties’ relationship maybe disclosed in public filings with the Securities
and Exchange Commission or any other commission, regulator, or public register or to its investors as necessary. If a Party intends
to make any such disclosure in a public filing with a commission or agency as described in the preceding sentence, that Party will
make reasonable efforts to provide a draft of the proposed disclosure to the other Party, so that the other Party may have an opportunity
to comment and/or provide suggestions to the disclosing Party prior to the time of the public filing.

 

    	3

     

    

 

3.7           Counterparts.
This Agreement may be executed in counterparts, each of which is deemed an original, but all of which together are deemed to be
one and the same agreement.

 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement
as of the Effective Date.

 

	MYND ANALYTICS, INC.	 	RSJ INVESTMENTS SICAV A.S. ACTING ON BEHALF OF ITS SUB-FUND RSJ GRADUS PODFOND, RSJ INVESTMENT SICAV A.S.
	 	 	 
	By :______/s/ George C. Carpenter IV	 	By :_________/s/ Libor Winkler
	Name: George C. Carpenter IV	 	 
	Title: Chief Executive Officer	 	Printed name: Libor Winkler
	 	 	Title: chairman of the board of the directors of RSJ Investments investicni spolecnost a.s., a company serving as a member of the board of RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfond, RSJ Investments SICAV a.s.

 

    	4EX-10.1

 Exhibit 10.1 

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE
TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 
 PROMISSORY NOTE 

 

			
	 Principal Amount: $300,000
	  	Dated as of October 18, 2018
		  	New York, New York

 Gores Metropoulos, Inc., a Delaware corporation (the “Maker”), promises to pay to the order
of Gores Metropoulos Sponsor LLC or its registered assigns or successors in interest (the “Payee”), or order, the principal sum of Three Hundred Thousand Dollars ($300,000) or such lesser amount as shall have been advanced by Payee
to Maker and shall remain unpaid under this Note on the Maturity Date (as defined below) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer
of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note. 

1.       Principal. The entire unpaid principal balance of Note shall be payable on the earlier of:
(i) September 30, 2019, or (ii) the date on which Maker consummates an initial public offering of its securities (such earlier date, the “Maturity Date”). The principal balance may be prepaid at any time. Under no
circumstances shall any individual, including but not limited to any officer, director, employee or shareholder of the Maker, be obligated personally for any obligations or liabilities of the Maker hereunder. 

2.       Drawdown Requests. Maker and Payee agree that Maker may request, from time to time, up to Three
Hundred Thousand Dollars ($300,000) in draw downs under this Note to be used for costs and expenses related to Maker’s formation and the proposed initial public offering of its securities (the “IPO”). Principal of this Note may
be drawn down from time to time prior to the Maturity Date upon written request from Maker to Payee (each, a “Drawdown Request”). Each Drawdown Request must state the amount to be drawn down, and must not be an amount less than Ten
Thousand Dollars ($10,000). Payee shall fund each Drawdown Request no later than three (3) business days after receipt of a Drawdown Request; provided, however, that the maximum amount of drawdowns outstanding under this Note at any time may
not exceed Three Hundred Thousand Dollars ($300,000). No fees, payments or other amounts shall be due to Payee in connection with, or as a result of, any Drawdown Request by Maker. 

3.       Interest. No interest shall accrue on the unpaid principal balance of this Note. 

4.       Application of Payments. All payments shall be applied first to payment in full of any costs
incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

 5.       Events of Default. The following shall constitute an event of default (“Event of
Default”): 
 (a)       Failure to Make Required Payments. Failure by Maker to pay the
principal amount due pursuant to this Note within five (5) business days of the date specified above. 

 (b)       Voluntary Bankruptcy, Etc. The
commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee,
custodian, sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become
due, or the taking of corporate action by Maker in furtherance of any of the foregoing. 

(c)       Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having
jurisdiction in the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker
or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive
days. 
 6.       Remedies. 

(a)       Upon the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by
written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable hereunder, shall become immediately due and payable without presentment, demand, protest
or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding. 

(b)       Upon the occurrence of an Event of Default specified in Sections 5(b) or 5(c), the unpaid
principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee. 

7.       Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment
for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker
by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution,
exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in
whole or in part in any order desired by Payee. 
 8.       Unconditional Liability. Maker hereby waives
all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be
affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with
respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder. 

9.       Notices. All notices, statements or other documents which are required or contemplated by this
Agreement shall be: (i) in writing and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to
the number most recently provided to such party or such other address or fax number as may be designated in writing by such party and (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other
electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of
written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail. 

 10.       Construction. THIS NOTE SHALL BE CONSTRUED
AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF. 

11.       Severability. Any provision contained in this Note which is prohibited or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such provision in any other jurisdiction. 
 12.       Trust Waiver.
Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any distribution of or from the trust account to be established in which the
proceeds of the IPO conducted by the Maker (including the deferred underwriters discounts and commissions) and the proceeds of the sale of the warrants issued in a private placement to occur prior to the consummation of the IPO are to be deposited,
as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any
Claim against the trust account for any reason whatsoever. 
 13.       Amendment; Waiver. Any amendment
hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee. 

14.       Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be
made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void. 

[Signature page follows] 

 IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note
to be duly executed by the undersigned as of the day and year first above written. 
  

			
	Gores Metropoulos, Inc.
		
	By:	 	 /s/ Alec Gores

		 	Name: Alec Gores
		 	Title:   Chief Executive Officer

 Acknowledged and Agreed to 

as of the date first written above. 
  

			
	GORES METROPOULOS SPONSOR LLC
		
	By:	 	 /s/ Alec Gores

	Name:	 	AEG Holdings, LLC
	Title:	 	Manager

 [Signature Page to Promissory Note]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]